Madhavi Mulay
16 May 2026
Strengthening Strategic Leadership to Build Enduring Pharmaceutical Businesses
Worth Willion Group is pleased to announce the appointment of Dr. Nagaraj Gowda to its Board of Directors for its Pharmaceutical Manufacturing business.
Dr. Gowda brings over two decades of leadership experience spanning pharmaceutical research and development, product strategy, innovation, business development, and healthcare entrepreneurship. As the Founder and Managing Director of Abhinavayan Biotech Pvt. Ltd., he has led the development of integrated scientific and business solutions that bridge discovery, development, and commercialization.
His appointment reflects Worth Willion Group's commitment to building enduring pharmaceutical enterprises through strong governance, scientific excellence, and long-term value creation.
Commenting on the appointment, Dr. Nagaraj Gowda said:
"I am honoured to join the Board of Worth Willion Group at an exciting stage of its journey. The Group's vision of preserving founder-built businesses while strengthening them for sustainable, long-term growth strongly resonates with me. I look forward to working with the leadership team to build resilient pharmaceutical manufacturing businesses that create lasting value for customers, employees, and future generations."
Worth Willion Group follows a long-term ownership philosophy, focusing on acquiring and strengthening businesses across pharmaceuticals, healthcare, and other essential industries. Through disciplined operations, strategic stewardship, and continuous value creation, the Group aims to preserve the legacy of founders while positioning businesses for sustainable growth.
Dr. Gowda's strategic insight into pharmaceutical innovation, manufacturing, and life sciences is expected to play an important role as the Group expands its presence in pharmaceutical manufacturing and pursues new growth opportunities.
About Worth Willion Group
Worth Willion Group acquires and stewards enduring businesses across pharmaceuticals, healthcare, and essential industries. Guided by its philosophy of Building Legacies, Compounding Businesses, the Group focuses on:
Selective Acquisition
Operational Strengthening
Long-Term Compounding
By partnering with founder-led businesses, Worth Willion Group preserves entrepreneurial legacies while creating stronger, more resilient organizations for generations to come.